Refine
Year of publication
Document Type
- Preprint (446)
- Article (207)
- Working Paper (2)
Has Fulltext
- yes (655)
Is part of the Bibliography
- no (655)
Keywords
- Heavy Ion Experiments (16)
- Hadron-Hadron Scattering (7)
- Hadron-Hadron scattering (experiments) (6)
- Collective Flow (4)
- Heavy-ion collision (4)
- Epilepsy (3)
- AChE (2)
- Brassica napus (2)
- Crude oil (2)
- EROD (2)
- Embryo toxicity (2)
- Heavy Quark Production (2)
- Jets (2)
- Jets and Jet Substructure (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Quark-Gluon Plasma (2)
- Seizure (2)
- WAF (2)
- 140Ce (1)
- ALICE detector (1)
- Angiomyolipoma (1)
- Aniridia (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Anticonvulsant (1)
- Aphakia (1)
- Araneae (1)
- Artificial iris (1)
- Bioaccumulation (1)
- Biodiversity (1)
- Biomarkers (1)
- Biotransformation (1)
- Boosted Jets (1)
- C-clamp (1)
- CEP68 (1)
- CVID (1)
- Cerebrovascular disorders (1)
- Chemical dispersant (1)
- Chemical dispersants (1)
- Coincidence measurement (1)
- Collective Flow, (1)
- Conservation biology (1)
- Costs (1)
- Dark Pools (1)
- Dark Trading (1)
- Dispersant (1)
- Dispersant toxicity (1)
- Double Volume Caps (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Endocrine disruption (1)
- Endothelium (1)
- Environmental impact (1)
- Estrogen receptor (1)
- European Society for Immunodeficiencies (ESID) (1)
- Everolimus (1)
- Fibre/foam sandwich radiator (1)
- GLM (1)
- Genetics (1)
- Genotoxicity (1)
- German PID-NET registry (1)
- Hard Scattering (1)
- Health information (1)
- Health-seeking behaviour (1)
- Helpline (1)
- IOL scleral Fixation (1)
- IgG substitution therapy (1)
- In situ burning (1)
- In vitro (1)
- Ionisation energy loss (1)
- Isoproterenol (1)
- Jet Physics (1)
- Jet Substructure (1)
- LHC (1)
- Landscape ecology (1)
- Landschaftsökologie (1)
- Liquidity (1)
- MTOR inhibitor (1)
- Material budget (1)
- MiFID II (1)
- Multi-Parton Interactions (1)
- Multi-wire proportional drift chamber (1)
- Neural network (1)
- Nf2 (1)
- Nuclear resonance fluorescence (1)
- Ocular trauma (1)
- Oil spill assessment (1)
- Oil spills (1)
- Oil toxicity (1)
- Oxidative stress (1)
- PID prevalence (1)
- Particle and Resonance Production (1)
- Particle correlations and fluctuations (1)
- Pb–Pb collisions (1)
- Pest-crop interactions (1)
- Price Efficiency (1)
- Proteinkinase (1)
- Pygmy Dipole Resonance (1)
- QCD (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quasi-particle phonon model (1)
- Rapps (1)
- Rare diseases (1)
- Rhabdomyoma (1)
- STED superresolution (1)
- Schädling (1)
- Sociodemographic characteristics (1)
- Spatial scales (1)
- Stroke (1)
- Subependymal giant cell astrocytoma (1)
- Swimming behavior (1)
- TR (1)
- TSC (1)
- Telemedicine (1)
- Tracking (1)
- Transition radiation detector (1)
- Trigger (1)
- U2-OS (1)
- VASP (1)
- Water accommodated fractions (1)
- Xenon-based gas mixture (1)
- Yamane (1)
- ZF-L (1)
- Zebrafish (1)
- ames fluctuation assay (1)
- cAMP (1)
- cGMP (1)
- cell therapy (1)
- centrosome (1)
- centrosome linker (1)
- chromosomal aberrations (1)
- crude oil (1)
- dE/dx (1)
- detector (1)
- epigeic spiders (1)
- epigäische Spinnen (1)
- experimental results (1)
- generalist predators (1)
- generalistische Prädatoren (1)
- graft-versus host (1)
- health information exchange (1)
- heavy ion experiments (1)
- hemorrhage (1)
- hospital exemption (1)
- lactate (1)
- mTOR inhibitor (1)
- mesenchymal stromal cell (1)
- micronucleus assay (1)
- oxidative stress (1)
- pelvic injury (1)
- pelvic packing (1)
- primary immunodeficiency (PID) (1)
- qualitative research (1)
- quality control (1)
- quark gluon plasma (1)
- rare diseases (1)
- refined fuels (1)
- refractory aGvHD (1)
- registry for primary immunodeficiency (1)
- rootletin (1)
- steroid-resistant aGvHD (1)
- transplantation (1)
- γ-ray spectroscopy (1)
Institute
- Physik (626)
- Frankfurt Institute for Advanced Studies (FIAS) (600)
- Informatik (573)
- Medizin (17)
- Biowissenschaften (4)
- Institut für Ökologie, Evolution und Diversität (3)
- Biochemie und Chemie (1)
- Biodiversität und Klima Forschungszentrum (BiK-F) (1)
- Center for Financial Studies (CFS) (1)
- ELEMENTS (1)
The first measurements of femtoscopic correlations with the particle pair combinations π±K0S in pp collisions at s√=13 TeV at the Large Hadron Collider (LHC) are reported by the ALICE experiment. Using the femtoscopic approach, it is shown that it is possible to study the elusive K∗0(700) particle that has been considered a tetraquark candidate for over forty years. Boson source parameters and final-state interaction parameters are extracted by fitting a model assuming a Gaussian source to the experimentally measured two-particle correlation functions. The final-state interaction is modeled through a resonant scattering amplitude, defined in terms of a mass and a coupling parameter, decaying into a π±K0S pair. The extracted mass and Breit-Wigner width, derived from the coupling parameter, of the final-state interaction are found to be consistent with previous measurements of the K∗0(700). The small value and increasing behavior of the correlation strength with increasing source size support the hypothesis that the K∗0(700) is a four-quark state, i.e. a tetraquark state. This latter trend is also confirmed via a simple geometric model that assumes a tetraquark structure of the K∗0(700) resonance.
The first measurements of femtoscopic correlations with the particle pair combinations π±K0S in pp collisions at s√=13 TeV at the Large Hadron Collider (LHC) are reported by the ALICE experiment. Using the femtoscopic approach, it is shown that it is possible to study the elusive K∗0(700) particle that has been considered a tetraquark candidate for over forty years. Boson source parameters and final-state interaction parameters are extracted by fitting a model assuming a Gaussian source to the experimentally measured two-particle correlation functions. The final-state interaction is modeled through a resonant scattering amplitude, defined in terms of a mass and a coupling parameter, decaying into a π±K0S pair. The extracted mass and Breit-Wigner width, derived from the coupling parameter, of the final-state interaction are found to be consistent with previous measurements of the K∗0(700). The small value and increasing behavior of the correlation strength with increasing source size support the hypothesis that the K∗0(700) is a four-quark state, i.e. a tetraquark state. This latter trend is also confirmed via a simple geometric model that assumes a tetraquark structure of the K∗0(700) resonance.
Agricultural intensification is a major threat to biological diversity worldwide. Land management activities enhancing landscape diversity are therefore regarded as a key strategy to halt species loss in cultural landscapes. Diverse and abundant communities of predatory arthropods, e.g. spiders (Araneae), have a high potential to suppress pest populations (Symondson et al. 2002) and could therefore contribute to allow reductions of pesticide use. Crop fields alone are usually not able to sustain diverse and individual-rich populations of predatory arthropods, because agricultural management results in disturbances and habitat deteriorations (harvest, soil cultivation, pesticide application) that kill or drive away large parts of the populations. Therefore semi-natural and perennial habitats in agricultural landscapes are considered to be of great importance for beneficial arthropods. On the one hand they offer refuge habitats in times when arable fields are hostile, e.g. fields with bare grounds during winter (Schmidt & Tscharntke 2005). On the other hand, viable populations of predatory arthropods in semi-natural habitats can serve as sources for (re-) colonisation of arable fields (Schmidt & Tscharntke 2005). Because of these exchanges between crop and non-crop areas it is important to include the surrounding landscape when investigating field-scale processes. We investigated the relations between spider assemblages in arable fields and the surrounding landscape in 29 fields of winter oilseed rape (OSR) in an agricultural landscape in eastern Austria. The objectives of this study were to estimate (1) how much spider assemblages in oilseed rape fields are influenced by the surrounding landscape, (2) the relative influence of landscape variables compared to field-scale variables and (3) at which spatial scales landscape variables are effective.
In agroecological research it has been appreciated only fairly recently that plant-insect interactions and other ecological processes depend on scales much larger than a single habitat (Wiens et al. 1997). Crop-pest interactions have mainly been studied on single pest species by focusing either on the impact of field parameters or on landscape structure but only rarely included both factors (Östman et al. 2001). Here we investigated how the abundances of three major insect pest species in oilseed rape (OSR) responded to field parameters and landscape characteristics at various spatial scales. Pest species considered in the current study include (i) ceutorhynchid stem weevils that lay eggs in leaf petioles or midribs of OSR plants while the larvae tunnel in the stems; (ii) pollen beetles that feed on pollen and destroy flower buds and (iii) brassica pod midge that lay eggs into OSR pods where the hatched larvae consume the seeds as well as tissue of the pod walls and cause the pods to split prematurely (Alford et al. 2003). Studying these different groups of pests is especially important because they attack different parts of the crop, use different habitats as overwintering sites and also differ in their mobility; with the exception of pollen beetles these pest species have never been studied in a landscape context. The specific objectives of this study were to determine (i) whether the major OSR pest species differ in their relation to field and landscape characteristics and (ii) at which spatial scales landscape variables are effective.
Background: Tuberous sclerosis complex (TSC), a multisystem genetic disorder, affects many organs and systems, characterized by benign growths. This German multicenter study estimated the disease-specific costs and cost-driving factors associated with various organ manifestations in TSC patients. Methods: A validated, three-month, retrospective questionnaire was administered to assess the sociodemographic and clinical characteristics, organ manifestations, direct, indirect, out-of-pocket, and nursing care-level costs, completed by caregivers of patients with TSC throughout Germany. Results: The caregivers of 184 patients (mean age 9.8 ± 5.3 years, range 0.7–21.8 years) submitted questionnaires. The reported TSC disease manifestations included epilepsy (92%), skin disorders (86%), structural brain disorders (83%), heart and circulatory system disorders (67%), kidney and urinary tract disorders (53%), and psychiatric disorders (51%). Genetic variations in TSC2 were reported in 46% of patients, whereas 14% were reported in TSC1. Mean total direct health care costs were EUR 4949 [95% confidence interval (95% CI) EUR 4088–5863, median EUR 2062] per patient over three months. Medication costs represented the largest direct cost category (54% of total direct costs, mean EUR 2658), with mechanistic target of rapamycin (mTOR) inhibitors representing the largest share (47%, EUR 2309). The cost of anti-seizure drugs (ASDs) accounted for a mean of only EUR 260 (5%). Inpatient costs (21%, EUR 1027) and ancillary therapy costs (8%, EUR 407) were also important direct cost components. The mean nursing care-level costs were EUR 1163 (95% CI EUR 1027–1314, median EUR 1635) over three months. Total indirect costs totaled a mean of EUR 2813 (95% CI EUR 2221–3394, median EUR 215) for mothers and EUR 372 (95% CI EUR 193–586, median EUR 0) for fathers. Multiple regression analyses revealed polytherapy with two or more ASDs and the use of mTOR inhibitors as independent cost-driving factors of total direct costs. Disability and psychiatric disease were independent cost-driving factors for total indirect costs as well as for nursing care-level costs. Conclusions: This study revealed substantial direct (including medication), nursing care-level, and indirect costs associated with TSC over three months, highlighting the spectrum of organ manifestations and their treatment needs in the German healthcare setting.
We present a measurement of e+e− pair production in central PbAu collisions at 158A GeV/c. As reported earlier, a significant excess of the e+e− pair yield over the expectation from hadron decays is observed. The improved mass resolution of the present data set, recorded with the upgraded CERES experiment at the CERN-SPS, allows for a comparison of the data with different theoretical approaches. The data clearly favor a substantial in-medium broadening of the ρ spectral function over a density-dependent shift of the ρ pole mass. The in-medium broadening model implies that baryon induced interactions are the key mechanism to the observed modifications of the ρ meson at SPS energy.
Background: The approval of everolimus (EVE) for the treatment of angiomyolipoma (2013), subependymal giant cell astrocytoma (2013) and drug-refractory epilepsy (2017) in patients with tuberous sclerosis complex (TSC) represents the first disease-modifying treatment option available for this rare and complex genetic disorder. Objective: The objective of this study was to analyse the use, efficacy, tolerability and treatment retention of EVE in patients with TSC in Germany from the patient’s perspective. Methods: A structured cross-age survey was conducted at 26 specialised TSC centres in Germany and by the German TSC patient advocacy group between February and July 2019, enrolling children, adolescents and adult patients with TSC. Results: Of 365 participants, 36.7% (n = 134) reported the current or past intake of EVE, including 31.5% (n = 115) who were taking EVE at study entry. The mean EVE dosage was 6.1 ± 2.9 mg/m2 (median: 5.6 mg/m2, range 2.0–15.1 mg/m2) in children and adolescents and 4 ± 2.1 mg/m2 (median: 3.7 mg/m2, range 0.8–10.1 mg/m2) in adult patients. An early diagnosis of TSC, the presence of angiomyolipoma, drug-refractory epilepsy, neuropsychiatric manifestations, subependymal giant cell astrocytoma, cardiac rhabdomyoma and overall multi-organ involvement were associated with the use of EVE as a disease-modifying treatment. The reported efficacy was 64.0% for angiomyolipoma (75% in adult patients), 66.2% for drug-refractory epilepsy, and 54.4% for subependymal giant cell astrocytoma. The overall retention rate for EVE was 85.8%. The retention rates after 12 months of EVE therapy were higher among adults (93.7%) than among children and adolescents (88.7%; 90.5% vs 77.4% after 24 months; 87.3% vs 77.4% after 36 months). Tolerability was acceptable, with 70.9% of patients overall reporting adverse events, including stomatitis (47.0%), acne-like rash (7.7%), increased susceptibility to common infections and lymphoedema (each 6.0%), which were the most frequently reported symptoms. With a total score of 41.7 compared with 36.8 among patients not taking EVE, patients currently being treated with EVE showed an increased Liverpool Adverse Event Profile. Noticeable deviations in the sub-items ‘tiredness’, ‘skin problems’ and ‘mouth/gum problems’, which are likely related to EVE-typical adverse effects, were more frequently reported among patients taking EVE. Conclusions: From the patients’ perspective, EVE is an effective and relatively well-tolerated disease-modifying treatment option for children, adolescents and adults with TSC, associated with a high long-term retention rate that can be individually considered for each patient. Everolimus therapy should ideally be supervised by a centre experienced in the use of mechanistic target of rapamycin inhibitors, and adverse effects should be monitored on a regular basis.
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1–25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0–88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%—subcutaneous; 29%—intravenous; 1%—unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.
We show that "quasi-dark" trading venues, i.e., markets with somewhat non-transparent trading mechanisms, are important parts of modern equity market structure alongside lit markets and dark pools. Using the European MiFID II regulation as a quasi-natural experiment, we find that dark pool bans lead to (i) volume spill-overs into quasi-dark trading mechanisms including periodic auctions and order internalization systems; (ii) little volume returning to transparent public markets; and consequently, (iii) a negligible impact on market liquidity and short-term price efficiency. These results show that quasi-dark markets serve as close substitutes for dark pools and consequently mitigate the effectiveness of dark pool regulation. Our findings highlight the need for a broader approach to transparency regulation in modern markets that takes into consideration the many alternative forms of quasi-dark trading.